Radiopharmaceuticals and Tracers

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

PET vs. SPECT, nuclear imaging advances

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both modalities also have suffered setbacks with radiopharmaceuti...

Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving medical isotopes in the United States.  In 2012,...
Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have entered into a strategic agreement for the future supply of...
A new analysis from the Phase III SELECT (Study of (E7080) LEnvatinib in Differentiated Cancer of the Thyroid) trial of lenvatinib (E7080) in the treatment of...
Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Application (sNDA) for...
Navidea Biopharmaceuticals' Inc. Lymphoseek (technetium Tc 99m tilmanocept) injection is U.S. Food and Drug Administration (FDA)-
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the...
The U.S. Food and Drug Administration (FDA) designated the Society of Nuclear Medicine and Molecular Imaging's (SNMMI's) ...

Articles

Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Application (sNDA) for...
June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept...
myocardial perfusion, PET/CT, Siemens, Biograph, mCT
The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon...
Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify...

Video Center

All major technology advances in the world of radiology and imaging are unveiled or highlighted at...
6 weeks 2 days ago
Remember the race to map the human genome, when the widest international collaboration in history...
10 weeks 6 days ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
15 weeks 1 day ago
The CME webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" will educate participants in the state of the art clinical and emerging...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
The webinar "Any Image, Anywhere" explains the new ways radiologists and clinicians can boost productivity, optimize scarce resources, and connect their...

Comparison Charts

Sorry there is no data available